Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Recipharm, Follicum Ink Clinical Supply Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Recipharm, Follicum Ink Clinical Supply Pact

Recipharm to produce drug candidate FOL-005 for a clinical trial

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Recipharm has signed a partnership agreement with Follicum AB to formulate and produce the drug candidate FOL-005 for a clinical trial. Recipharm will also develop and validate the analytical methods required. In preclinical studies, FOL-005 has both stimulated and inhibited hair growth effectively even at low doses.
 
“Preparations for the clinical study are well under way, and we have now established ties with partners that we feel confident in. Recipharm is successful in its field and has a strong track record. We look forward to the finished product, which is expected to be ready at the end of the year, in time for the launch of the clinical study,” says Jan Alenfall, chief executive officer of Follicum.
 
“We have extensive experience in the development of pharmaceuticals for clinical trials and are very excited to be able to contribute to the development of this product,” said Maria Lundberg, general manager of Recipharm in Solna.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics